Ann: New Publication Demonstrates ATH434 is Neuroprotective, page-8

so many opportunities to load up under .03 over the year, its actually been fantastic from a trading perspective. i have been adding today every hour to try and get the best price and i was just about to execute another order at .037 and someone swiped it.... obviously.

make no mistake, the best value add right now is 434. id say 95% of the companies efforts are and should be focused on 434. im all for pbt2 but that is not the focus right now as much preparation and tons of work is needed to successfully launch this P2 trial.

furthermore, just to address the continuous speculation on PBT2, i have called the company and have confirmed that the primary focus is ath434 so i wouldnt expect too much news on pbt2 for now. i cant see the company having the money, time, or (wo)manpower currently to make significant advances on pbt2 outside of whats already known.

gltah and dyor